Thomas McNerney & Partners

Archive

Celator(R) Pharmaceuticals Announces Listing on NASDAQ Under Symbol "CPXX"
November 7, 2013

Zogenix Receives FDA Approval for Zohydro(TM) ER (hydrocodone bitartrate) Extend-Release Capsules
October 25, 2013

Auspex Appoints Pratik Shah As CEO And Expands Executive Team
October 17, 2013

Celator® Pharmaceuticals Receives U.S. Patent On Proprietary Liposome Composition
August 29, 2013

Ocera Therapeutics Announces Completion Of Merger With Tranzyme
July 15, 2013

CASMED Receives FDA Clearance for Next-Generation Vital Signs Monitor And Blood Pressure Solution
June 4, 2013

Valeant Pharmaceuticals International, Inc. To Acquire Bausch + Lomb For $8.7 Billion
May 27, 2013

Packaging Coordinators, Inc. Acquires AndersonBrecon From AmerisourceBergen
May 13, 2013

Celator® Pharmaceuticals Raises $32.5 Million Completing A $39.3 Million Private Placement Financing
April 30, 2013

Thomas, McNerney & Partners Joins With National Venture Capital Association And Other Industry Leaders In Briefing Congress On Need For Policies That Will Support Investment In Medical Innovation
April 25, 2013

Tranzyme Pharma And Ocera Therapeutics Announce Merger Agreement
April 24, 2013

CASMED Announces FDA Approval Of Next Generation FORE-SIGHT® Absolute Tissue Oximeter
April 17, 2013

The New England Journal Of Medicine Publishes Clinical Study Of Minimally-Invasive Device for Treatment Of Reflux Disease
February 21, 2013

Auspex Pharmaceuticals Closes $25 Million Series D Financing
November 8, 2012

Thomas, McNerney & Partners Invests In Keystone Dental, Inc.
October 22, 2012

Cebix Announces Positive Results of ERSATTA Phase 1/2 Trial In Peripheral Neuropathy
October 17, 2012

Clarus Therapeutics Top-line Results Show Oral Testosterone Replacement Candidate, CLR-610, Meets Phase 3 Study Primary Efficacy Endpoint
September 25, 2012

Mallinckrodt Announces Definitive Agreement to Acquire CNS Therapeutics, Inc.
September 24, 2012

Clarus Therapeutics Strengthens Patent Estate With Issuance Of A U.S. Patent Directed To Formulations And Method Of Use Of Clarus' Oral Testosterone Product
September 19, 2012

Locus Development, Inc. Merges With InVitae Division Of Genomic Health
August 8, 2012

Zogenix Announces U.S. Food And Drug Administration (FDA) Acceptance For Review Of Zohydro ER(TM) New Drug Application (NDA) For Treatment Of Chronic Pain
July 16, 2012

The Leukemia & Lymphoma Society And Celator Pharmaceuticals Announce $5 Million Partnership To Support Phase 3 Development Of CPX-351 For AML
July 2, 2012

AxioMed Spine Corporation Receives CE Mark For Freedom® Cervical Disc
May 15, 2012

Zogenix Submits New Drug Application (NDA) To U.S. Food And Drug Administration (FDA) For Zohydro(TM) For Treatment Of Chronic Pain
May 2, 2012

FDA Approves LINX® System For The Treatment Of Reflux Disease
March 27, 2012

Torax Medical’s LINX® Reflux Management System Receives Unanimous Recommendation From FDA Advisory Panel
January 13, 2012

VertiFlex®, Inc. Completes Enrollment of The Superion® Pivotal IDE Clinical Trial
December 13, 2011

InnoPharma Completes $15 Million Series A Financing
December 1, 2011

CASMED Raises $15 Million in Private Placement
June 9, 2011

Asante Solutions Receives FDA Clearance for Pearl™ Insulin Pump
May 17, 2011

Thomas, McNerney & Partners Expands Team and Moves West Coast Office to San Diego
February 23, 2011

Zogenix Announces Completion of Enrollment in ZX002 Phase 3 Efficacy Study
February 10, 2011

VertiFlex®, Inc. Announces Financing and New Investment Partner
February 1, 2011

Thomas, McNerney & Partners Promotes Two Members of its Investment Team
January 25, 2011

Boston Scientific to Acquire Atritech
January 19, 2011

Celator® Pharmaceuticals Raises $20 Million in Series D Financing
September 1, 2010

Sandoz to Acquire Oriel Therapeutics, Gaining Rights to Portfolio of Respiratory Products Targeting Asthma and COPD
April 19, 2010

Atritech Completes $30 Million Financing
March 25, 2009

Thomas, McNerney & Partners Promotes Three Members of Its Investment Team
January 8, 2009

Amarin Announces Private Placement for Up to $60 Million
May 14, 2008

Wuxi Pharmatech to Acquire Apptec Laboratory Services, Inc.
January 3, 2008

Pfizer to Acquire Coley Pharmaceutical Group
November 16, 2007

Tranzyme Pharma Closes New $20 Million Financing
November 1, 2007

Thomas, McNerney & Partners Expands Team on East and West Coasts
October 17, 2007

Thomas, McNerney & Partners Invests in Asante Solutions Inc.
January 12, 2007

Galil Medical, a Leader in Cryotherapy Solutions, Announces $52 Million Financing
December 11, 2006

Quinnova Pharmaceuticals, Inc. Completes $13.6 Million Series A Financing
November 28, 2006

Thomas, McNerney & Partners Closes $375 Million Life Science & Medical Technology Fund
September 6, 2006

Zogenix, Inc. Created Through Aradigm Asset Sale of Intraject® Needle-Free Technology
August 28, 2006

Thomas, McNerney & Partners Is Lead Investor in Osteobiologics, Acquired By Smith & Nephew
July 11, 2006

Coley Pharmaceutical Group Sets Price for Initial Public Offering
August 10, 2005

Torax Medical Completes $10 Million Series B Financing
June 28, 2005

Pfizer, Coley Pharmaceutical Group Enter Into Exclusive Global License for the Development and Commercialization of Promune for Cancers
March 24, 2005

Thomas, McNerney & Partners Announces Pratik Shah, Ph.D. as New Venture Partner in San Francisco Office
November 8, 2004

Coley Pharmaceutical Group Raises $25 Million in Private Financing
September 29, 2004

Thomas, McNerney & Partners Invests in Clarus Therapeutics, Inc.
February 13, 2004

Osteobiologics, Inc. Closes $9.2 Million Financing
October 3, 2003

Coley Pharmaceutical Group Announces $35 Million Private Financing
August 25, 2003

Thomas, McNerney & Partners, LLC, Raises $216 Million for Its Inaugural Health Care Private Equity Fund
May 6, 2003